SSE Ticker: 600085

Beijing Tongrentang Co., Ltd.

同仁堂

Listing Date: 19970625

Authorized Representative: 高振坤

Board: Main A

Industry Classification: Manufacturing

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

Post date May 16, 2022 — 08:44 Post Lock

Li Ning is also in the game! Why are the traditional chain giants all interested in your coffee money? -Finance-financial world

Post date May 14, 2022 — 19:54 Post Lock

Pay 499 yuan, Li Ning will send you a cup of coffee

Post date May 14, 2022 — 19:11 Post Lock

The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value

Post date May 14, 2022 — 13:05 Post Lock

The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value_ Oriental Fortune Net

Post date May 14, 2022 — 11:00 Post Lock

Weekend Securities丨The industry is booming, and the pharmaceutical sector has long-term investment value_Shenzhen Hotline

Post date May 13, 2022 — 21:04 Post Lock

The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network

Post date May 13, 2022 — 20:12 Post Lock

Can Li Ning, with nearly 6,000 stores, become a new dark horse in the trillion-dollar coffee market? -Finance-financial world

Post date May 10, 2022 — 22:40 Post Lock

Time-honored Brand Guangyuyuan: Inheritance and Innovation of Chinese Brands

Post date May 10, 2022 — 13:21 Post Lock

The policy is favorable for traditional Chinese medicine enterprises to welcome a "good start" in the first quarter _ Oriental Fortune Net

Post date May 10, 2022 — 13:11 Post Lock

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

Post date May 10, 2022 — 10:07 Post Lock

In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure

Post date May 9, 2022 — 09:01 Post Lock

Many constituent stocks of Xinhua News Agency's National Brand Index performed strongly

Post date May 9, 2022 — 08:58 Post Lock

Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network

Post date May 9, 2022 — 08:47 Post Lock

31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? Interface News

Post date May 7, 2022 — 15:50 Post Lock

31.4 billion was thrown on the list, and 8 stocks fell by more than 15% in April. Is Gao Yi Feng Liu's heavyweight stocks worth following in the first quarter? _Sina Finance_Sina.com

Post date May 7, 2022 — 15:48 Post Lock

8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter? _Finance Bay EHZ / Financial Diamond Value Drive

Post date May 7, 2022 — 15:46 Post Lock

8 companies with 31.4 billion on the list fell by more than 15% in April. Is Gao Yi Feng Liu's heavy holding stocks worth following in the first quarter?

Post date May 7, 2022 — 15:45 Post Lock

April's Popular Private Equity List Announced: Linyuan and Oriental Harbor are on the list, and Gao Yi's assets of 55.4 billion are exposed.

Post date May 7, 2022 — 10:53 Post Lock

Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery

Post date May 6, 2022 — 22:37 Post Lock

Want to see more data? Registered subscribers can see all the data.